Co-Diagnostics price target lowered to $6 from $9 at H.C. Wainwright

H.C. Wainwright analyst Yi Chen lowered the firm’s price target on Co-Diagnostics to $6 from $9 and keeps a Buy rating on the shares post the Q3 results.